Chris Andersen has spent a career treating subarachnoid haemorrhage, and he opens this episode by admitting we might have wasted a fortune treating vasospasm without evidence to show for it. Host Oli Flower and Chris Andersen, co-conveners of ISAH 2026, dig into why SAH care hasn't seen the revolution ischaemic stroke has, why delayed cerebral ischaemia (DCI) is the field's great unsolved problem, and why fewer than 10% of SAH trials have ever asked patients what actually matters to them. Chris Andersen is a neurocritical care specialist and co-convener of ISAH 2026, the International Conference on Subarachnoid Haemorrhage, running 17–20 November in Sydney. In this episode: <ul class= "[li_&]:mb-0 [li_&]:mt-1 [li_&]:gap-1 [&:not(:last-child)_ul]:pb-1 [&:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3 print:block print:space-y-1" dir="ltr"> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 02:56 — If you could solve one problem in SAH in the next decade, what would it be?</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 03:52 — Have outcomes actually improved in the last 15 years?</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 05:52 — The treatment we've poured money into without proof it works</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 08:53 — Is DCI the ARDS of subarachnoid haemorrhage?</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 10:30 — Precision medicine: substance or buzzword?</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 13:32 — What AI can realistically do for SAH care in the next 5 years</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 16:56 — The best debates coming to ISAH 2026</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 19:12 — Lumbar drains and the EARLYDRAIN trial, three years on</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 22:23 — Platform trials: the future, or an expensive way to spend grant money?</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 26:23 — What clinicians get wrong about recovery — and what patients actually want measured</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 32:11 — The tech that sounds like science fiction but might be routine in 10 years</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 35:40 — Why SAH needs a global alliance, not another society</li> <li class= "font-claude-response-body whitespace-normal break-words pl-2"> 39:26 — Lightning round: most overrated treatment, biggest unanswered question, and a prediction Chris might regret</li> </ul> ISAH 2026 runs 17–20 November in Sydney. View the program and register at <a href= "https://www.subarachnoid.org/register">subarachnoid.org</a>

Chris Andersen has spent a career treating subarachnoid haemorrhage, and he opens this episode by admitting we might have wasted a fortune treating vasospasm without evidence to show for it. Host Oli Flower and Chris Andersen, co-conveners of ISAH 2026, dig into why SAH care hasn't seen the revolution ischaemic stroke has, why delayed cerebral ischaemia (DCI) is the field's great unsolved problem, and why fewer than 10% of SAH trials have ever asked patients what actually matters to them. Chris Andersen is a neurocritical care specialist and co-convener of ISAH 2026, the International Conference on Subarachnoid Haemorrhage, running 17–20 November in Sydney. In this episode: 02:56 — If you could solve one problem in SAH in the next decade, what would it be? 03:52 — Have outcomes actually improved in the last 15 years? 05:52 — The treatment we've poured money into without proof it works 08:53 — Is DCI the ARDS of subarachnoid haemorrhage? 10:30 — Precision medicine: substance or buzzword? 13:32 — What AI can realistically do for SAH care in the next 5 years 16:56 — The best debates coming to ISAH 2026 19:12 — Lumbar drains and the EARLYDRAIN trial, three years on 22:23 — Platform trials: the future, or an expensive way to spend grant money? 26:23 — What clinicians get wrong about recovery — and what patients actually want measured 32:11 — The tech that sounds like science fiction but might be routine in 10 years 35:40 — Why SAH needs a global alliance, not another society 39:26 — Lightning round: most overrated treatment, biggest unanswered question, and a prediction Chris might regret ISAH 2026 runs 17–20 November in Sydney. View the program and register at subarachnoid.org

Chris Andersen has spent a career treating subarachnoid haemorrhage, and he opens this episode by admitting we might have wasted a fortune treating vasospasm without evidence to show for it. Host Oli Flower and Chris Andersen, co-conveners of ISAH 2026, dig into why SAH care hasn't seen the revolution ischaemic stroke has, why delayed cerebral ischaemia (DCI) is the field's great unsolved problem, and why fewer than 10% of SAH trials have ever asked patients what actually matters to them. Chris Andersen is a neurocritical care specialist and co-convener of ISAH 2026, the International Conference on Subarachnoid Haemorrhage, running 17–20 November in Sydney. In this episode: <ul> <li> 02:56 — If you could solve one problem in SAH in the next decade, what would it be?</li> <li> 03:52 — Have outcomes actually improved in the last 15 years?</li> <li> 05:52 — The treatment we've poured money into without proof it works</li> <li> 08:53 — Is DCI the ARDS of subarachnoid haemorrhage?</li> <li> 10:30 — Precision medicine: substance or buzzword?</li> <li> 13:32 — What AI can realistically do for SAH care in the next 5 years</li> <li> 16:56 — The best debates coming to ISAH 2026</li> <li> 19:12 — Lumbar drains and the EARLYDRAIN trial, three years on</li> <li> 22:23 — Platform trials: the future, or an expensive way to spend grant money?</li> <li> 26:23 — What clinicians get wrong about recovery — and what patients actually want measured</li> <li> 32:11 — The tech that sounds like science fiction but might be routine in 10 years</li> <li> 35:40 — Why SAH needs a global alliance, not another society</li> <li> 39:26 — Lightning round: most overrated treatment, biggest unanswered question, and a prediction Chris might regret</li> </ul> ISAH 2026 runs 17–20 November in Sydney. View the program and register at <a href="https://www.subarachnoid.org/register" rel="noopener noreferrer">subarachnoid.org</a>

Andersen — Have We Actually Improved SAH Outcomes in 15 Years?

Catherine Bell takes us through how to troubleshoot problems commonly encountered when looking after patients who have an external ventricular drain (EVD) in situ. Issues with using brain tissue oxygen monitors are also discussed. A highly practical session aimed at bedside clinicians. This presentation was delivered by Catherine Bell at <a href="https://codachange.org/" target="_blank" rel= "noopener">CODA2022</a>. Want more content about EVD? Visit <a href="https://bit.ly/neuroresus" target="_blank" rel= "noopener">neuroresus.com</a> or <a href= "http://eepurl.com/iuNLLk">subscribe</a> to be notified of new podcast releases via email. To express your interest in attending the 2024 Neuroresus live course, <a href= "https://docs.google.com/forms/d/1tRRLf55kAv8g1PC1_8bO016M3ecEEbz1KLroIuYEojE/edit?ts=64b63fda">click here</a>.

Catherine Bell takes us through how to troubleshoot problems commonly encountered when looking after patients who have an external ventricular drain (EVD) in situ. Issues with using brain tissue oxygen monitors are also discussed. A highly practical session aimed at bedside clinicians. This presentation was delivered by Catherine Bell at CODA2022. Want more content about EVD? Visit neuroresus.com or subscribe to be notified of new podcast releases via email. To express your interest in attending the 2024 Neuroresus live course, click here.

Catherine Bell takes us through how to troubleshoot problems commonly encountered when looking after patients who have an external ventricular drain (EVD) in situ. Issues with using brain tissue oxygen monitors are also discussed. A highly practical session aimed at bedside clinicians. This presentation was delivered by Catherine Bell at <a href="https://codachange.org/" rel="noopener noreferrer">CODA2022</a>. Want more content about EVD? Visit <a href="https://bit.ly/neuroresus" rel="noopener noreferrer">neuroresus.com</a> or <a href="http://eepurl.com/iuNLLk" rel="noopener noreferrer">subscribe</a> to be notified of new podcast releases via email. To express your interest in attending the 2024 Neuroresus live course, <a href="https://docs.google.com/forms/d/1tRRLf55kAv8g1PC1_8bO016M3ecEEbz1KLroIuYEojE/edit?ts=64b63fda" rel="noopener noreferrer">click here</a>.

EVD tips and tricks

Associate Professor Lindy Jeffree: Lifting the lid on decompressive craniectomy. From CICM ASM PROGRAM 2019.

Associate Professor Lindy Jeffree: Lifting the lid on decompressive craniectomy. From CICM ASM PROGRAM 2019.

Lifting the lid on decompressive craniectomy

Professor Andrew Udy: Emerging neuromonitoring techniques in TBI. From CICM ASM PROGRAM 2019.

Professor Andrew Udy: Emerging neuromonitoring techniques in TBI. From CICM ASM PROGRAM 2019.

Emerging neuromonitoring techniques in TBI

Dr Paul Goldrick: Does ICP monitoring in TBI really help? From CICM ASM PROGRAM 2019.

Dr Paul Goldrick: Does ICP monitoring in TBI really help? From CICM ASM PROGRAM 2019.

Does ICP monitoring in TBI really help?

Dr Peter Pereira: Tropical envenomation. From CICM ASM PROGRAM 2019.

Dr Peter Pereira: Tropical envenomation. From CICM ASM PROGRAM 2019.

Tropical envenomation

Professor Michael Reade: Blasts. From CICM ASM PROGRAM 2019.

Professor Michael Reade: Blasts. From CICM ASM PROGRAM 2019.

Blasts

Professor Mark Midwinter: Mass Casualty & Terrorism. From CICM ASM PROGRAM 2019.

Professor Mark Midwinter: Mass Casualty & Terrorism. From CICM ASM PROGRAM 2019.

Professor Mark Midwinter: Mass Casualty &amp; Terrorism. From CICM ASM PROGRAM 2019.

Mass Casualty & Terrorism

Dr Anthony Holley: Burns. From CICM ASM PROGRAM 2019.

Dr Anthony Holley: Burns. From CICM ASM PROGRAM 2019.

Burns

Professor Michael Reade: Trials on the horizon. From CICM ASM PROGRAM 2019.

Professor Michael Reade: Trials on the horizon. From CICM ASM PROGRAM 2019.

Trials on the horizon

Dr Ben Parkinson: Pelvis. From CICM ASM PROGRAM 2019.

Dr Ben Parkinson: Pelvis. From CICM ASM PROGRAM 2019.

Pelvis

Dr Andrew Potter: Airway. From CICM ASM PROGRAM 2019.

Dr Andrew Potter: Airway. From CICM ASM PROGRAM 2019.

Airway

Podcasts on topics relevant to intensive care medicine

Share Neuro Resus

Sign up to save your podcasts

Neuro Resus

Neuro Resus episodes

About Neuro Resus

More shows like Neuro Resus

If Books Could Kill

Big Small Talk